We recently wrote about the sustained-release growth hormone LB03002, which will probably appear on the market fairly soon. This isn’t the only sustained-release growth hormone in the pharmaceuticals pipeline. The American company Versartis [versatis.com] recently published the results of the first human trial with VRS-317, a growth hormone analogue that only requires one injection a […]

Read More...